Skip to main content

Savara

Savara Inc is an American clinical-stage biopharmaceutical enterprise headquartered in Austin, Texas. The company specializes in the research, development, and commercialization of innovative pulmonary therapeutics for rare respiratory diseases, anchored by its proprietary drug development pipeline. Principal revenue is currently earned through research collaborations, grant funding, and capital financing arrangements as clinical pipelines advance. Savara Inc is publicly listed on the Nasdaq Stock Market.

2 of the funds FundTelligence covers report a position in Savara.

Legal name
Savara Inc
Sector
Health Care
Country
United States
Funds holding it
2

Funds holding Savara

Loading...